Currently, Jack Anders occupies the position of Principal Financial & Accounting Officer at Revolution Medicines, Inc. Mr. Anders is also Vice President for Anders & Sons, Inc.
In his past career Mr. Anders occupied the position of Vice President-Finance of Assertio Therapeutics, Inc.
Jack Anders received an undergraduate degree from the University of California, Los Angeles.
|09/01/2022||10,000||Award at $0 per share.||0|
|06/17/2022||406||Disposition at $17.75 per share.||7,207|
|03/17/2022||159||Disposition at $18.62 per share.||2,961|
|03/01/2022||11,600||Award at $0 per share.||0|
|12/17/2021||170||Disposition at $24.41 per share.||4,150|
|09/17/2021||166||Disposition at $30.02 per share.||4,984|
|06/17/2021||160||Disposition at $34.12 per share.||5,460|
|03/04/2021||7,400||Award at $0 per share.||0|
|10/13/2020||10,000||Disposition at $44 per share.||440,000|
|10/13/2020||10,000||Derivative/Non-derivative trans. at $2.68 per share.||26,800|
|10/06/2020||10,000||Disposition at $40 per share.||400,000|
|10/06/2020||10,000||Derivative/Non-derivative trans. at $2.68 per share.||26,800|